Diversity in forest management promotes biodiversity
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Dec-2025 14:11 ET (24-Dec-2025 19:11 GMT/UTC)
Collaborative research by the University of Tokyo and RIKEN Center for Biosystems Dynamics Research has led to the development of a new method for simultaneously synthesizing all transfer RNA (tRNA) required for protein synthesis in a reconstituted translation system in vitro.
Researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences, together with their collaborators, uncovered the molecular innovation that led to the origin of Type V CRISPR-Cas immune systems.
Drawing on cutting-edge technology and interdisciplinary expertise, researchers are launching Menopause Health Engineering, a new initiative uniting faculty from Cornell’s Ithaca campus and Weill Cornell Medicine, to uncover how menopause shapes health and disease, and to develop urgently needed treatment strategies. The inaugural team includes nine faculty across four departments, with a core in the Meinig School of Biomedical Engineering.
Trying to curb coyote populations may be a lost cause, according to a new University of Georgia study.
Acute promyelocytic leukemia (APL) represents a paradigm of targeted therapy in hematologic malignancies. Once regarded as the most fatal form of leukemia due to its rapid onset and severe hemorrhagic risk, APL was fundamentally transformed in the 20th century when Dr. Tingdong Zhang from Harbin Medical University, China discovered that arsenic trioxide (ATO) could effectively treat patients, achieving remission rates of up to 90% and converting it into the most curable acute leukemia. Extensive mechanistic studies have demonstrated that ATO exerts therapeutic effects by inducing apoptosis and promoting differentiation of APL cells. More recently, a study published in Science Bulletin using single-cell sequencing further revealed that ATO not only directly eliminates leukemic cells but also reshapes the tumor microenvironment through modulation of lymphocyte activity, underscoring its multifaceted role in APL treatment.
For the first time, researchers at Umeå University have observed the same type of programmed cell death in microalgae as in humans. The discovery, published in Nature Communications, shows that this central biological process is older than previously thought.